IMAX (NYSE:IMAX - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.17 earnings per share for the quarter, missing analysts' consensus estimates of $0.31 by ($0.14), Zacks reports. The firm had revenue of $92.67 million during the quarter, compared to analyst estimates of $104.08 million. IMAX had a net margin of 7.40% and a return on equity of 8.60%.
IMAX Price Performance
Shares of IMAX traded down $0.91 during mid-day trading on Friday, hitting $26.03. The company's stock had a trading volume of 1,170,438 shares, compared to its average volume of 707,780. The stock has a market capitalization of $1.38 billion, a price-to-earnings ratio of 53.11, a PEG ratio of 1.49 and a beta of 1.22. The firm has a 50-day moving average price of $24.65 and a 200 day moving average price of $23.00. IMAX has a fifty-two week low of $14.94 and a fifty-two week high of $27.77.
Insider Buying and Selling
In other IMAX news, CFO Natasha Fernandes sold 2,957 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $25.52, for a total value of $75,462.64. Following the completion of the sale, the chief financial officer now owns 14,883 shares in the company, valued at $379,814.16. This represents a 16.58 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert D. Lister sold 55,910 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $25.50, for a total value of $1,425,705.00. Following the sale, the executive vice president now owns 138,889 shares of the company's stock, valued at approximately $3,541,669.50. This represents a 28.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 65,176 shares of company stock worth $1,662,110 in the last three months. 24.08% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
IMAX has been the topic of a number of research analyst reports. Wedbush reissued an "outperform" rating and issued a $32.00 price target on shares of IMAX in a research note on Thursday. Wells Fargo & Company upped their price target on IMAX from $26.00 to $32.00 and gave the stock an "overweight" rating in a report on Thursday. Macquarie boosted their price target on IMAX from $28.00 to $30.00 and gave the stock an "outperform" rating in a research note on Thursday. JPMorgan Chase & Co. boosted their target price on shares of IMAX from $25.00 to $27.00 and gave the stock a "neutral" rating in a research report on Friday. Finally, Barrington Research lifted their price objective on shares of IMAX from $30.00 to $32.00 and gave the stock an "outperform" rating in a report on Thursday. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $30.67.
Check Out Our Latest Analysis on IMAX
About IMAX
(
Get Free Report)
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Featured Stories

Before you consider IMAX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.
While IMAX currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.